Number of participants with a complication attributed to the index infection · patients with sore throat
1 finding from 1 review
Number of participants in need of re‐consultation by the end of · patients with sore throat
1 finding from 1 review
All‐cause mortality and malaria mortality · people with suspected malaria
1 finding from 1 review
no estimate extracted
9428 participants
Low
Hospitalization · people with suspected malaria
1 finding from 1 review
no estimate extracted
9428 participants
Low
Hospital mortality – non‐randomised studies ( · adult on acute hospital wards at risk of clinical deterioration
2 findings from 1 review
AOR 0.52 [0.32, 0.85]
2792 participants
Low
no estimate extracted
Studies not reported
Very low
Length of hospital stay · adult on acute hospital wards at risk of clinical deterioration
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
HR 0.91 [0.83, 0.98]
2733 participants
Low
Adverse events (unexpected cardiac or respiratory arrest) – non‐randomised studies ( · adult on acute hospital wards at risk of clinical deterioration
2 findings from 1 review
AOR 0.94 [0.79, 1.13]
364094 participants
Low
no estimate extracted
Studies not reported
Very low
Composite outcome – randomised trials Composite outcome of incidence (events divided by number of eligible participants admitted to the hospital during the study period) of cardiac arrests without a pre‐existing NFR order, unplanned ICU admissions... · adult on acute hospital wards at risk of clinical deterioration
1 finding from 1 review
AOR 0.98 [0.83, 1.16]
364094 participants
Moderate
Composite outcome – non‐randomised studies Composite endpoint of cardiopulmonary arrest, unplanned ICU admission or death per 1000 admitted patients ( · adult on acute hospital wards at risk of clinical deterioration
1 finding from 1 review
AOR 0.85 [0.72, 0.99]
57858 participants
Low
Unplanned ICU admission – non‐randomised trial ( · adult on acute hospital wards at risk of clinical deterioration
2 findings from 1 review
AOR 1.04 [0.89, 1.21]
364094 participants
Low
no estimate extracted
Studies not reported
Very low
ICU readmission – non‐randomised studies · adult on acute hospital wards at risk of clinical deterioration
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Repeated need for rapid tranquillisation ‐ needing additional injection during 24 hours · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes repeated need for rapid tranquillisation ‐ needing additional… compared with COMBINATIONS: b. HALOPERIDOL + LORAZEPAM (very low certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation ‐ more than 1 injection · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes repeated need for rapid tranquillisation ‐ more that 1 injection compared with OTHER ANTIPSYCHOTIC: b. CHLORPROMAZINE (very low certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation ‐ more than 1 injection · psychosis‐induced aggression or agitation
HALOPERIDOL probably leads to higher repeated need for rapid tranquillisation ‐ more than 1 injection compared with OTHER ANTIPSYCHOTIC: c. DROPERIDOL (moderate certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation ‐ not reported · patients with psychosis‐induced aggression or agitation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Repeated need for rapid tranquillisation ‐ needing additional benzodiazepine · patients with psychosis‐induced aggression or agitation
HALOPERIDOL showed no clear difference in repeated need for rapid tranquillisation ‐ needing additional… compared with OTHER ANTIPSYCHOTIC: h. RISPERIDONE (low certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes repeated need for rapid tranquillisation compared with OTHER ANTIPSYCHOTIC: i. THIOTHIXENE (very low certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation ‐ more than 3 injections · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes repeated need for rapid tranquillisation ‐ more than 3 injections compared with OTHER ANTIPSYCHOTIC: k. ZUCLOPENTHIXOL ACETATE (very low certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation ‐ needing additional injection · patients with psychosis‐induced aggression or agitation
HALOPERIDOL may leads to lower repeated need for rapid tranquillisation ‐ needing additional… compared with OTHER ANTIPSYCHOTIC: a. ARIPIPRAZOLE (low certainty).
1 finding from 1 review
Repeated need for rapid tranquillisation ‐ more than 1 injection · patients with psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes repeated need for rapid tranquillisation more than 1 injection compared with BENZODIAZEPINE: b. LORAZEPAM (very low certainty).
1 finding from 1 review